前PDrug:集成可解释的神经网络和知识图,用于基于途径的药物重用
Junku Kim1, Hojoong Jang1, Youngjun Park2
1Department of Computer Engineering, Chungbuk National University, Cheongju, Republic of Korea.
Computers in biology and medicine
|January 30, 2025
概括
新型神经网络模型ExPDrug将基因表达数据与精准医学中的药物重定位联系起来. 它增强了疾病预测,并通过整合生物途径和知识图表来识别潜在的候选药物.
科学领域:
- 计算生物学是一种计算生物学.
- 基因组学就是基因组学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 精准医学依靠分子概况进行个性化治疗,但将基因表达数据与药物发现联系起来很困难.
- 目前的方法很难有效地将转录基因洞察力转化为可操作的临床应用.
研究的目的:
- 引入ExPDrug,一种基于途径的药物重定位的神经网络模型.
- 通过将转录基因数据与生物医学知识图表集成来增强疾病表型预测.
- 为了促进对临床应用的潜在候选药物的识别.
主要方法:
- ExPDrug 将从转录基因数据的生物途径与生物医学知识图集成.
- 层级相关性传播 (LRP) 解释了路径贡献.
- 一个随机步行与重启 (RWR) 算法优先考虑候选药物.
主要成果:
- 与现有方法相比,ExPDrug提高了疾病表型预测的准确性.
- 该模型成功地识别了现有文献支持的潜在药物候选者.
- 在将转录组数据与药物重用联系起来时,ExPDrug表现出卓越的性能.
结论:
- 通过将转录组数据连接到药物重新用途,ExPDrug为精密医学提供了一种变革性的方法.
- 这个模型有可能改善复杂疾病的治疗策略.
- "ExPDrug"有助于将分子洞察力转化为临床药物发现.
相关概念视频
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Structure-Activity Relationships and Drug Design
493
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
493
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
G Protein-coupled Receptors
11.2K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.2K
Drug-Receptor Interactions
4.8K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.8K


